Proya Cosmetics Expands European R&D Footprint Amid Steady Market Performance

Proya Cosmetics Co., Ltd. (ticker 603605.SS) closed the trading session on Tuesday, 20 October 2026, with its share price unchanged at the close, reflecting a flat 0 % movement over the 24‑hour period that ended at 11:57 PM Central Europe. The stock continues to trade around CNY 57.5 on the Shanghai Stock Exchange, with an active supply of approximately 391.5 million shares and a market capitalization of CNY 22.6 billion. In the past 24 hours, roughly CNY 280.6 million worth of shares exchanged hands.

A Quiet Trading Day, Yet a Strategic Leap Forward

While the market offered a muted response to Proya’s recent announcement, the company has taken a decisive step toward positioning itself at the forefront of cosmetic innovation. Proya disclosed the opening of a new laboratory within its Europe Innovation Center located in Suresnes, France. The 450‑square‑metre facility is outfitted with cutting‑edge equipment and is designed to harness European expertise in longevity science, skin biology, biotechnology, and sustainable ingredient development. By integrating this centre with its existing research hubs in Hangzhou and Shanghai, Proya intends to translate scientific breakthroughs into commercial products more efficiently.

The inauguration was followed by participation in the COSMETIC 360 trade show, where Proya showcased its latest research findings and engaged in innovation challenges centred on regenerative technologies. Executives highlighted the company’s commitment to merging global scientific capabilities with localized innovation, a strategy they believe will drive future growth in the cosmetics sector.

Trading Context and Market Sentiment

The laboratory launch comes at a time when Proya’s share price has experienced a modest uptick of 1.65 % since the end of the previous month. The 200‑day simple moving average sits at CNY 59.36, and the stock’s 52‑week high of CNY 77.66 was recorded on 22 October 2025, while its 52‑week low of CNY 53.78 occurred on 30 September 2026. These figures suggest a period of consolidation around a stable support level, with the company’s recent news providing a catalyst for potential upside.

Peer Performance Snapshot

Proya’s contemporaries on the Shanghai Stock Exchange have also shown little movement in the last 24 hours:

  • Zhejiang Crystal‑Optech (002273.SZ) closed flat at CNY 20.99, maintaining a market capitalization of CNY 27 billion. The company recently experienced a limit‑up surge, buoyed by a broader rally in the consumer‑electronics sector, particularly in foldable‑screen and AI‑enabled device segments.
  • Leo (002131.SZ) remains at CNY 4.17 with a market capitalization of CNY 26.9 billion.
  • Hengdian Dmegc (002056.SZ) trades at CNY 17.2, also valued at CNY 27.1 billion, and carries a price‑to‑earnings ratio of 15.4.
  • Glory View L (301396.SZ) is listed at CNY 126.28, with a market cap of CNY 26.9 billion. The company’s flagship AI‑focused fund has suffered a significant decline in net asset value, reflecting the volatility of concentrated AI investments.
  • Jiangxi Hongdu Aviation (600316.SS) is priced at CNY 37.49, with a market cap of CNY 27 billion and a notably high price‑to‑earnings ratio of 570.5, indicative of aggressive growth expectations.

Proya’s Strategic Positioning

Proya Cosmetics Co., Ltd. is a leading Chinese manufacturer and distributor of skin‑care products. Headquartered in Hangzhou, the company operates across approximately 30 cities in China and beyond, leveraging a distribution network that includes department stores, boutique chains, supermarkets, and electronic commerce platforms. Its product portfolio, marketed under the PROYA, UZERO, ANYA, YOYA, and CATS & ROSES brands, is widely available throughout Asia. With the expansion of its European research capabilities, Proya signals a clear intent to blend its domestic strengths with international scientific expertise, positioning itself for sustainable growth in an increasingly competitive global cosmetics market.